Phase Clinical Development News Today

Bring this collection of great talent and Close Friends together today for this conversation, and that Susan Glasser of the new yorker kindly agreed to host today. Susan, thank you, and over to you. Susan thank you so much, steve, and to everyone who is joining us on this incredible allstar panel of experts we have with us today. I cannot think of a group that as a citizen, and not just as an observer, im hoping you can help us provide, if not definitive answers, at least some thoughts on what t...

Steve welcome to todays Bob Schieffer series, conversation on covid19 societal instability, where are we heading. I want to offer special thanks to the foundation that supports this series, as well as the Schieffer School of communications at tcu. Several staff here at csis have worked hard to pull this together. Emma, among the foremost of the staff, made this possible. We also have travis hopkins, Clifford Johnson special thanks to them. Lastly, we are thrilled we can bring this collection of ...

International studies hosted the discussion. Steve welcome to todays Bob Schieffer series, conversation on covid19 societal instability, where are we steve welcome to todays Bob Schieffer series, conversation on covid19 societal instability, where are we heading. I want to offer special thanks to the foundation that supports this series, as well as the Schieffer School of communications at tcu. Several staff here at csis have worked hard to pull this together. Emma, among the foremost of the sta...

Thanks to the foundation that supports this series, as well as the Schieffer School of communications at tcu. S havel staff here at csi worked hard to pull this together. Emma, among the foremost of the staff, made this possible. We also have travis hopkins, Clifford Johnson special thanks to them. Lastly, we are thrilled we can bring this collection of great talent and Close Friends together today for this conversation, and that Susan Glasser of the new yorker kindly agreed to host today. Susan...

SAN DIEGO, Aug. 07, 2023 -- Viracta Therapeutics, Inc. , a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients...

Press release content from PR Newswire. The AP news staff was not involved in its creation.